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Mice Treated with an Antibiotic Cocktail Containing Metronidazole 
Show Attenuated Allergy Responses through the Induction of 
Regulatory T Cells in the Intestinal Mucosa
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Abstract : This study sought to determine whether antibiotic treatments affect 
the pathogenesis of allergic diseases.  We demonstrated that mice treated with a 
mixture of four antibiotic agents （ampicillin, neomycine, metronidazole, and vanco-
mycin） showed signicantly decreased antigen-specic IgE production compared to 
control mice, whereas mice treated with the same cocktail without metronidazole 
showed no change in IgE production compared to controls.  Regulatory T cell 
suppression induced by particular antibody combinations is a possible mechanism of 
this effect, with an increased frequency of regulatory T cells also observed in the 
mesenteric lymph nodes （MLN） of mice treated with the mixture of four antibiot-
ics, but not in the second cocktail without metronidazole.  Our antibiotic treatments 
also dramatically decreased the diversity of mouse intestinal microbiota compared 
to control mice, based on 16SrRNA analysis of the cecum fecal composition.  In 
conclusion, mice treated with antibiotic mixtures containing metronidazole, but 
not those treated without metronidazole, showed attenuated allergy responses and 
increased induction of regulatory T cells in the mucosa.
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Introduction
　Allergic diseases including food allergy, hay fever, bronchial asthma, allergic sinusitis, and atopic 
dermatitis are steadily increasing in prevalence, particularly in highly industrialized countries.  In 
contrast, no such increases have been noted in developing countries 1）.  One possible explanation 
for this geographical anomaly is the higher frequency of antibiotic administration to infants with 
infectious diseases in developed countries leading to more cases of gut microbiota dysbiosis.  This 
could in turn result in an insufficient mature immune system that predisposes the individual to 
Th2 allergic responses 2）.  Indeed, frequency of antibiotic usage is positively correlated with the 
incidence of allergic diseases 3）, although interestingly, the excess use of antibiotics is considered a 
risk factor for allergic diseases in infants, but not in adolescents and adults who possess a fully 
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mature immune system 4）.  The mechanisms underlying this difference remain unclear, as does the 
risk level for administering antibiotics to allergy patients is unclear.
　Among the various types of allergic diseases, antigen-specific IgE on mast cells under the 
mucosal surface plays a crucial role in the induction of allergy 5）.  After antigen exposure, these 
IgE molecules recognize the antigen, and histamines are released from the activated mast cells 
to increase downstream allergic responses 6）.  Thus, the presence of antigen-specific IgE is a risk 
factor for all allergic diseases in the host.  On the other hand, regulatory T cells can participate 
in inhibiting allergic responses 7）, presumably by suppressing conventional T cell responses to 
activate allergic responses through multiple pathways, including TGF-β, IL-10, IL-35, CTLA-4, 
and Fas-L8）.  In addition, regulatory T cell activity in the gut mucosa is closely related to the 
composition of gut microbiota 9）, with certain species of bacteria and / or their metabolites, such 
as short-chain fatty acids, implicated in the induction of regulatory T cells in the gut mucosa10）.  
　In the present study, we investigated whether antibiotic usage affects allergic disease conditions, 
the frequency of regulatory T cells, and the gut microbiota.  Moreover, we also investigated 
whether specific antibiotics change the risk of allergic diseases in a mouse allergy model.
Materials and methods
Mice and treatments
　Female Balb / c mice were purchased from Oriental Yeast Co., Ltd.（Tokyo, Japan）.  All mice 
were housed under specific pathogen-free conditions and according to the animal protocol 
guidelines of the Institutional Animal Care and Use Committee of Showa University （Protocol 
No. 07034）.  Antibiotic treatment of mice was performed according to previous reports11）.  Briefly, 
as shown in Figure 1, five-week-old mice were given ad libitum access to water or water 
containing antibiotics （ampicillin ［AMP ; 1 mg/ml］, neomycin ［NEO ; 1 mg/ml］, metronidazole 
［MNZ ; 1 mg/ml］, and vancomycin ［VCM ; 0.5 mg/ml］） from day 1 to 5 and from day 10 
to 15.  The day on which the administration of antibiotics was started was defined as day 1 
in the experiments.  In other experiments, mice received water containing a combination of 
three antibiotics from day 1 to 5 and from day 10 to 15.  Allergy was induced in some mice 
Fig. 1.  The experimental designs in the current study
Designs of the antibiotic administration experiments and the allergy induction model 
in the current study are shown.
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by intraperitoneal injection of 1 µg of ovalbumin and 0.1 mg of aluminum hydroxide （alum） 
（Thermo Scientific, IL, USA） at days 5 and 10, to increase the serum level of ovalbumin-specific 
IgE.  Serum was collected from the mice on day 20.
Measurement of ovalbumin-specific antibody
　Ovalbumin-specific IgE and the serum concentrations of IgG1 were measured by ELISA 
methods.   Briefly, ovalbumin （50 µg/ml） was coated onto 96-well immunoplates overnight.  After 
blocking with T20 （Thermo Scientific）, the serum sample or ovalbumin-specific IgE antibody 
（Ab） standard （Acris Antibodies, San Diego, CA, USA） and biotin-conjugated anti-mouse IgE 
Ab （Southern Biotech, Birmingham, AL, USA） were then plated in the wells and incubated 
for 1 h.  After washing, horseradish peroxidase （HRP）-conjugated streptavidin was added before 
the detection of ovalbumin-specific antibodies using a 3, 3', 5, 5'-tetramethylbenzidine （TMB） 
microwell peroxidase substrate system （KPL, Gaithersburg, MD, USA）.  Absorbance at 450 nm 
was measured after the addition of a stop solution 12）.  In the same way as above, serum 
concentrations of IgG1 were measured using ovalbumin-specific IgG1 Ab standard （Santa Cruz 
Biotechnology, Dallas, TX, USA） and biotin-conjugated anti-mouse IgG1 Ab.
Flow cytometry
　Mice were given water or water containing antibiotics from day 1 to 5, and then spleen and 
mesenteric lymph nodes （MLN） cell suspensions were prepared for flow cytometry, using the 
following antibodies : anti-CD16 / CD32 Ab as an Fc-blocker, FITC-conjugated anti-CD4 Ab, 
BV421-conjugated anti-CD25 Ab, Alexa Fluor-conjugated anti-Foxp3 Ab （BD Biosciences, San 
Jose, CA, USA）, BV650-conjugated anti-CD3 Ab, FITC-conjugated anti CD19 Ab, and PE / Cy7-
conjugated anti-IL-10 Ab （BioLegend, San Diego, CA, USA）.  A Zombie red Fixable Viability 
Kit （BioLegend） was used to exclude dead cells, according to the manufacturer’s protocol. 
Following the staining of surface antigens, intracellular Foxp3 staining was performed using a 
Transcription Factor Buffer set （BD Biosciences）13）.  For intracellular IL-10 staining, a single cell 
suspension was incubated with LPS （10 µg/ml）, PMA （50 ng/ml）, ionomycin （500 ng/ml）, and 
Brefeldin A （1 µg/ml） for 5 h at 37ºC followed by intracellular IL-10 staining performed using 
a Transcription Factor Buffer set 14）.  All cells were analyzed by an LSR Fortessa flow cytometer 
（BD Biosciences）.  Cells positive for CD4, CD25, and intracellular Foxp3 were identified as 
regulatory T cells, while those positive for CD19 and intracellular IL-10 were identified as 
regulatory B cells.
Microbiota composition analysis
　Mice were given water or water including antibiotics from day 1 to 5, and then the cecum 
contents were collected.  A microbiome composition analysis was performed by 16SrRNA sequence 
analysis at Techno Suruga Laboratory Co., Ltd.（Shizuoka, Japan）.  The bacterial count was 
determined by first culturing the cecum content suspensions serially diluted with PBS on Gifu 
Anaerobic Medium agar for 48 hours, and then calculating the Log10 colony forming units （CFU）/g.
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Statistical analysis
　Tukey’s test was used for multiple comparisons, while the t-test was used for comparisons 
between groups.  P values ＜ 0.05 were considered to indicate statistical significance.
Results
Antibiotic treatment attenuated the allergy responses in mice
　Mice first received a four-antibiotic mixture （AMP, NEO, MNZ, and VCM） from day 1 to 
5 and from 10 to 15, and then were injected with ovalbumin and alum to induce ovalbumin-
specific IgE and IgG1 responses.  The production of serum ovalbumin-specific IgE and IgG1 was 
significantly suppressed in the antibiotic-treated mice compared to control mice （antibiotic-treated 
vs. control : IgE : 71.5 ［53.0-76.0］ng/ml vs. 159.5 ［158.3-213.2］ng/ml ; IgG1 : 45.4 ［39.9-61.6］ng/ml 
vs. 85.2 ［80.5-120.0］ng/ml） （Fig. 2）.
Regulatory T cells induced mucosal immunity after treatment with the four-antibiotic mixture
　Based on the antibiotic-induced suppression of ovalbumin-specific IgE and IgG1 production, 
we next investigated the induction of regulatory T cells and B cells.  The MLN of mice treated 
with the four-antibiotic mixture （AMP, NEO, MNZ, VCM） from day 1 to 5 showed significantly 
increased numbers of regulatory T cells （the ratios of CD4＋ CD25＋ Foxp3＋ T cells to the 
total T cells） compared to the control mice （antibiotic-treated mice, 8.8％ ［8.6％-10.3％］; control 
mice, 5.3％ ［3.8％-6.0％］） （Fig. 3）.  In contrast, the frequencies of regulatory T cells and B cells 
in same mouse spleens were comparable to those of control mice.  Thus, administering one or 
more antibiotics increased the frequency of regulatory T cells in the MLN.
Regulatory T cells were induced by treatment only by the mixture of antibiotics with metronidazole
　We performed the following experiments to further decipher the effect of individual antibiotics 
on regulatory T cell activity.  Mice received the following mixtures of antibiotics （four agents 
Fig. 2.  The effect of antibiotic administration on the mouse allergy model
A mixture of four antibiotics was administered to the mice from day 1 to 5 and 
from day 10 to 15. The mice were injected with ovalbumin and alum on days 5 and 
15. Serum samples were collected on day 20. The concentrations of ovalbumin-specific 
IgE and IgG1 were measured by ELISA （n＝5-7）. ＊P＜ 0.05. 
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［AMP, NEO, MNZ, VCM］, three agents ［NEO, MNZ, VCM］, ［AMP, MNZ, VCM］, ［AMP, 
NEO, MNZ］, or ［AMP, NEO, VCM］） or autoclaved water.  The frequencies of regulatory T 
cells were as follows : 7.1％ （6.8-7.6％） for 4 agents, 6.4％ （6.3-6.4％） for NEO, MNZ, and 
VCM, 7.0％ （7.0-7.2％） for AMP, MNZ, and VCM, 6.9％ （6.2-7.4％） for AMP, NEO, and MNZ, 
5.4％ （5.2-5.5％） for AMP, NEO, and VCM, and 4.7％ （4.4-4.7％） for autoclaved water （Fig. 4）. 
The frequency of regulatory T cells was significantly lower in mice that received the antibiotic 
Fig. 3.   The frequencies of regulatory T cells in the spleen and mesenteric lymph nodes （MLN）,  
and the frequency of regulatory B cells in the spleen, as determined by flow cytometry
The frequencies of regulatory T cells and regulatory B cells in mice treated with the mixture of four 
antibiotic agents from day 1 to 5. MLN and Spleen samples were collected on day 5. 
A :  The frequency of CD4＋FOXP3＋CD25＋ cells （regulatory T cells） in the MLN of mice treated with 
four antibiotic agents and control mice. 
B :  The frequency of CD4＋FOXP3＋CD25＋ cells （regulatory T cells） in the spleen of mice treated with 
four antibiotic agents and control mice. 
C :  The frequency of IL-10＋CD19＋ cells （regulatory B cell） in the spleen of mice treated with four 
antibiotic agents and control mice （n＝ 5-7）. 
＊P＜ 0.05. NS : Not significant.
Fig. 4.  The frequency of regulatory T cells in the MLN, as determined by flow cytometry
Mice were treated with a mixture of three or four antibiotic agents from day 1 to 5. Spleen cells were 
obtained on day 5. The frequency of CD4＋FOXP3＋CD25＋ cells in the MLN from mice that received 
a mixture of three antibiotic agents （without MNZ） were significantly lower in comparison to the mice 
that received four antibiotic agents （n＝5）. 
A : ampicillin, M : metronidazole, N : neomycin, V : vancomycin. ＊P＜ 0.05. a : P＝0.053.
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mixtures without MNZ, in comparison to the mice that received four antibiotics.  Interestingly, 
mice treated with the three-antibody combinations without metronidazole showed significantly 
increased ovalbumin-specific IgE production compared to the mice treated with four antibiotics 
（71.6 ［58.0-73.2］ng/ml vs. 49.5 ［40.9-68.1］ng/ml）; however, no such differences were found in 
the production of ovalbumin-specific IgG1 （Fig. 5）.  Thus, the antibiotic mixtures containing 
MNZ induced regulatory T cells in the MLN of mice that suppressed the allergic response.
The 16SrRNA analysis and culturing revealed that antibiotic treatments cause remarkable change to 
the composition of gut microbiota
　We next investigated whether the microbiota composition was affected by antibiotic treatment. 
As shown in Figure 6, mice treated with the mixture of four antibiotics showed significantly 
reduced bacterial diversity in the microbiota compared to the control mice, with the microbiota 
dominated by Escherichia species.  On the other hand, the microbiota samples from mice treated 
with the three-antibiotic mixtures not containing metronidazole were dominated by Clostridium 
sensu stricto.  Moreover, bacterial counts in the feces of mice receiving antibiotic mixtures with 
and without MNZ were similarly reduced （Control : 8.43 log10CFU/g, 4 agents : 3.81 log10CFU/g, 
4 agents : 3.91 log10CFU/g）.  These results suggest that antibiotic treatment had a remarkable 
effect on the microbiota of mice.
Discussion
　It remains unclear whether antibiotic treatment is a risk factor for the exacerbation of allergic 
diseases or a beneficial factor that attenuates allergic diseases.  Moreover, no studies have 
Fig. 5.   The influence of antibiotic administration on the gut microbiota based on 
IgE and IgG1 levels
Mice were treated with a mixture of four antibiotic agents or three antibiotic agents 
without MNZ from day 1 to 5 and from day 10 to 15, and then injected with 
ovalbumin and alum on days 5 and 15. Serum samples were collected on day 20. The 
concentrations of ovalbumin-specific IgE and IgG1 were measured by ELISA （n＝7）. 
A : ampicillin, M : metronidazole, N : neomycin, V : vancomycin.
＊P＜0.05. NS : Not Significant.
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examined differences among antibiotic types with respect to allergic response.  The current study 
demonstrated in mice that administering mixtures of four and three antibiotic agents, but not 
three antibiotic agents without metronidazole, reduced the production of systemic antigen-specific 
IgE through inducing regulatory T cells into the mucosa.
　Several reports have linked usage of antibiotics in infancy and early childhood to an increased 
risk of allergic diseases due to changes in the composition of gut microbiota 15-17）.  In addition, 
epidemiological studies have shown differences in microbiota composition and less diversity in 
the microbiota of children with allergic diseases compared to healthy children 18，19）.  The gut 
microbiota, especially antibiotic-sensitive-bacteria, could potentially both limit the development 
pro-inflammatory cells and promote the maturation of regulatory cells.  Thus, antibiotic use 
in infancy and early childhood could lead to abnormal immune development.  Interestingly, 
our study also indicated that this effect might differ among antibiotic types.  Almqvist et al 20） 
indicated a strong relationship between the use of antibiotics to treat gram-positive bacterial 
infections and the development of allergic diseases, while no such relationship was observed 
with antibiotics used for gram-negative bacterial infections.  Moreover, use of antibiotics by adult 
patients with allergic diseases did not affect their clinical condition 4）.  Thus, we investigated 
whether antibiotic-sensitive bacteria in the gut microbiota could attenuate the induction of 
allergic diseases and / or exacerbate the development of allergic diseases, in association with 
modulation of the microbiota and host immunity.
　We showed that treatment with a cocktail of four antibiotic agents reduced systemic 
ovalbumin-specific IgE production, and it is possible that such a response could reflect the 
mucosal induction of regulatory T cells.  The gut microbiota in four-antibiotic treated mice 
was dominated by the Escherichia / shigella genus ; however, the overall diversity of the gut 
microbiota was decreased in comparison to control mice.  LPS and flagellin are present on the 
cell surface of the Escherichia / shigella genus （gram-negative bacteria）, and these molecules 
can stimulate peripheral naïve T cells via TLR-4 and TLR-5, respectively, inducing regulatory T 
cells 21）.  Therefore, inducing regulatory T cells might suppress IgE production by B cells through 
several immunosuppressive mechanisms 22）.  Indeed, LPS exposure can have a protective effect 
against Th2-type airway inflammation and airway hyperresponsiveness in murine models 23，24）. 
On the other hand, the ovalbumin-specific IgE production of mice treated with three antibiotic 
agents without metronidazole in this study was comparable to that of control mice.  One 
possible explanation for this apparent anomaly is that that the gut microbiota in the treated 
mice was dominated by the Clostridium sensu stricto genus, which is also a major component 
of the gut microbiota in infants with food allergy and is strongly associated with food allergy 
in infancy 25）.  Moreover, the prevalence of Clostridium sensu stricto is positively associated with 
IgE-mediated food allergy, although the mechanisms of serum IgE production in infants with 
Clostridium sensu stricto-associated food allergy are unknown 25）.
　In conclusion, we showed that treatment with a cocktail of four antibiotic agents attenuated 
allergic responses through the induction of regulatory T cells ; however, leaving metronidazole 
out of the treatment did not affect the allergy responses or induce regulatory T cells.  Further 
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studies are thus required to identify bacteria and / or metabolites, such as short-chain fatty acids, 
that induce regulatory T cells in the mucosa.  We will also investigate whether regulatory T cells 
in the MLN induced by treatment with the four-antibiotic cocktail can suppress antigen-specific 
IgE production, and in turn, allergic diseases using an adaptive transfer model.
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